Get the Stockscreener App
7.21
6.00%
-0.46
Lixte Biotechnology Holdings Inc stock is traded at $7.21, with a volume of 614.08K.
It is down -6.00% in the last 24 hours and up +0.00% over the past month.
Lixte Biotechnology Holdings Inc is a clinical-stage biopharmaceutical and proton cancer therapy company focused on identifying new targets for cancer drug development and developing and commercializing cancer therapies. The company's drug product pipeline is focused on inhibitors of protein phosphatase 2A, which is used to enhance cytotoxic agents, radiation, immune checkpoint blockers and other cancer therapies. Its product is LB-100 for Ovarian Clear Cell Carcinoma and Metastatic Colon Cancer. The company operates in a single reportable segment, which consists of the development of cancer treatments.
See More
Previous Close:
$7.67
Open:
$7.95
24h Volume:
614.08K
Relative Volume:
2.75
Market Cap:
$125.36M
Revenue:
-
Net Income/Loss:
$-7.29M
P/E Ratio:
-6.4186
EPS:
-1.1233
Net Cash Flow:
$-7.00M
1W Performance:
+0.00%
1M Performance:
+0.00%
6M Performance:
+142.76%
1Y Performance:
+111.44%
1-Day Range:
$7.00
$7.99
1-Week Range:
$7.00
$7.99
52-Week Range:
$2.36
$8.3773
Lixte Biotechnology Holdings Inc Stock (LIXT) Company Profile
Name
Lixte Biotechnology Holdings Inc
Sector
Industry
Phone
310 203 2902
Address
433 PLAZA REAL, BOCA RATON
Compare LIXT vs VRTX, REGN, ARGX, MRNA, RVMD
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
LIXT
Lixte Biotechnology Holdings Inc
|
7.21 | 125.36M | 0 | -7.29M | -7.00M | -1.1233 |
VRTX
Vertex Pharmaceuticals Inc
|
547.59 | 136.93B | 12.34B | 4.34B | 3.71B | 16.87 |
REGN
Regeneron Pharmaceuticals Inc
|
828.50 | 85.11B | 14.92B | 4.42B | 3.79B | 41.04 |
ARGX
Argen X Se Adr
|
1,011.11 | 64.95B | 4.16B | 1.29B | 734.26M | 19.58 |
MRNA
Moderna Inc
|
138.89 | 53.23B | 2.23B | -3.19B | -1.60B | -8.1462 |
RVMD
Revolution Medicines Inc
|
211.58 | 45.38B | 742.00K | -1.37B | -1.07B | -7.0731 |
Lixte Biotechnology Holdings Inc Stock (LIXT) Latest News
Lixte Biotechnology (NMAD) Stock Price, News & Analysis - MarketBeat
Vanguard Capital Management (LIXT) discloses 5.02% ownership in Lixte - Stock Titan
The AI Buildout Has a Power Problem, and the Grid Is Not Going to Solve It in Time - TradingView
Lixte Biotechnology Holdings (LIXT) Consolidates Near $7.21 as Stock Holds SteadyVolatility Smile - vinanet.vn
Nomad Power Solutions (NASDAQ: LIXT) plans 50M-share conversion and plan boost - Stock Titan
NOMAD Power Solutions Strengthens Subsidiary Executive Leadership - The Manila Times
NMAD Stock: Price, Forecast, Financials & AI Analysis - Intellectia AI
Lixte Biotechnology Holdings Inc. (LIXT) Q4 2024 Earnings: Net Loss Highlights Pre-Revenue StageEarnings Weakness Phase - vinanet.vn
Nomad Power unveils upgraded Voyager mobile storage series - TipRanks
Nomad Power Solutions (NASDAQ: NMAD) nearly doubles Voyager trailer energy - Stock Titan
What is the current Price Target and Forecast for NOMAD POWER SOL (NMAD) - Zacks Investment Research
LIXT Q4 2024 Earnings: Pre-Revenue Biotech Reports Net Loss as Cash Burn ContinuesGAAP Earnings Report - dars.gov.et
Nomad upgrades mobile energy storage capacity by over 50% - Investing.com South Africa
NOMAD Increases Voyager Fleet Energy Storage by up to 56%, Bringing Eagle and Falcon to 2.025 MWh - The Manila Times
NOMAD Power Solutions Announces Third-Generation Voyager Mobile Energy Storage Series With 50%+ More Capacity - Moomoo
NMAD: NOMAD POWER SOLBalance Sheet - Zacks Investment Research
Lixte Biotechnology (LIXT) Holds Steady at $7.21 as Support and Resistance Levels TightenIsland Reversal - DonanımHaber
symbol__ Stock Quote Price and Forecast - CNN
Cash per share of Lixte Biotechnology Holdings, Inc. – NASDAQ:NMAD - TradingView
Revenue per share of Lixte Biotechnology Holdings, Inc. – NASDAQ:NMAD - TradingView
ETFs Investing in Nomad Power Solutions, Inc. Stocks - TradingView
Price to book forward of Lixte Biotechnology Holdings, Inc. – NASDAQ:NMAD - TradingView
Free float of Nomad Power Solutions, Inc. – NASDAQ:NMAD - TradingView
News On Lixte Biotechnology Holdings Inc. (LIXT) Now Under NMAD - Moomoo
Total revenue of Lixte Biotechnology Holdings, Inc. – NASDAQ:NMAD - TradingView
CapEx per share of Lixte Biotechnology Holdings, Inc. – NASDAQ:NMAD - TradingView
Total liabilities & shareholders' equities of Lixte Biotechnology Holdings, Inc. – NASDAQ:NMAD - TradingView
Enterprise value of Lixte Biotechnology Holdings, Inc. – NASDAQ:NMAD - TradingView
Operating income of Nomad Power Solutions, Inc. – NASDAQ:NMAD - TradingView
Total liabilities of Lixte Biotechnology Holdings, Inc. – NASDAQ:NMAD - TradingView
Total debt of Lixte Biotechnology Holdings, Inc. – NASDAQ:NMAD - TradingView
Net debt of Lixte Biotechnology Holdings, Inc. – NASDAQ:NMAD - TradingView
Net income of Lixte Biotechnology Holdings, Inc. – NASDAQ:NMAD - TradingView
Net current asset value per share of Lixte Biotechnology Holdings, Inc. – NASDAQ:NMAD - TradingView
Nomad Power Solutions, Inc. Common Stock (NMAD) Historical Quotes - Nasdaq
Quick ratio of Lixte Biotechnology Holdings, Inc. – NASDAQ:NMAD - TradingView
Dilution adjustment of Lixte Biotechnology Holdings, Inc. – NASDAQ:NMAD - TradingView
Taxes of Lixte Biotechnology Holdings, Inc. – NASDAQ:NMAD - TradingView
Lixte Biotechnology Holdings, Inc. Balance Sheet – NASDAQ:NMAD - TradingView
Free cash flow of Lixte Biotechnology Holdings, Inc. – NASDAQ:NMAD - TradingView
Operating expenses (excl. COGS) of Lixte Biotechnology Holdings, Inc. – NASDAQ:NMAD - TradingView
Enterprise value to revenue forward of Lixte Biotechnology Holdings, Inc. – NASDAQ:NMAD - TradingView
Diluted earnings per share (diluted EPS) of Lixte Biotechnology Holdings, Inc. – NASDAQ:NMAD - TradingView
Cash flow from investing activities of Lixte Biotechnology Holdings, Inc. – NASDAQ:NMAD - TradingView
Cash flow from financing activities of Lixte Biotechnology Holdings, Inc. – NASDAQ:NMAD - TradingView
Diluted net income available to common stockholders of Lixte Biotechnology Holdings, Inc. – NASDAQ:NMAD - TradingView
Total common shares outstanding of Lixte Biotechnology Holdings, Inc. – NASDAQ:NMAD - TradingView
EBIT of Lixte Biotechnology Holdings, Inc. – NASDAQ:NMAD - TradingView
Return on equity % of Lixte Biotechnology Holdings, Inc. – NASDAQ:NMAD - TradingView
Average basic shares outstanding of Lixte Biotechnology Holdings, Inc. – NASDAQ:NMAD - TradingView
Price to cash flow ratio of Lixte Biotechnology Holdings, Inc. – NASDAQ:NMAD - TradingView
Lixte Biotechnology Holdings Inc Stock (LIXT) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.00%
3.22%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):